MONICA BUELT: Open Payments
NPI 1013428101 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 9 payments from 5 companies in 2025. Trend: 2023 $54 · 2024 $136 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| GENZYME CORPORATION | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $15 |
Products named: TEZSPIRE, DUPIXENT, NEFFY, PROPEL.
Industry payments across CO — which companies pay providers there.
